Although the GPX1 Pro198Leu polymorphism, in general, did not significantly correlate with panic disorder risk, the study found a plausible association of the C allele of the GPX1 Pro198Leu polymorphism, found to be more frequent in the female cohort, with PD development
Clinically, the ATTAIN Phase 3 program showed that orforglipron at its highest dose delivered a mean weight loss of 12.4% over 72 weeks, slightly less than the WEGOVY pills 13.6% at 64 weeks, but with a broader, more diverse patient population of over 3,000 participants
Antioxid and Redox Sign 34 (10), 811830
Sonia Hernndez-Daz, professor of epidemiology at Harvard T.H
The blood flow to bones is vital for skeletal health, and GLP-1RAs may improve it, while the precise processes are not entirely known